BAX and infectious otitis media: The present MF (30 and 60 mg/kg) supplementation caused significant positive modulation of Bax protein and noticeably reduction of the β-catenin protein appearance in rat’s colon, which could be a molecular mechanism behind lower ACF incidence and the chemoprotective action of MF in AOM-pre-treated rats.